CREB signaling in KRAS-driven lung adenocarcinoma

Georgia Giotopoulou (Patras, Greece)

Source: ERS Lung Science Conference 2017
Number: 3

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Georgia Giotopoulou (Patras, Greece). CREB signaling in KRAS-driven lung adenocarcinoma. ERS Lung Science Conference 2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
MEK5 promotes lung adenocarcinoma
Source: Eur Respir J, 53 (2) 1801327; 10.1183/13993003.01327-2018
Year: 2019



LSC - 2017 - CREB signaling in KRAS-driven lung adenocarcinoma
Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome
Year: 2017

Salinomycin suppresses TGF-ß1-induced EMT by down-regulating MMP-2,9 via AMPK-SIRT1 pathway in a non-small cell lung cancer
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017

cAMP response element-binding protein mediates immune-evasion of KRAS-mutant lung adenocarcinoma
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021


CDCA promotes non-small-cell lung cancer (NSCLC) migration by regulating Akt/Erk1/2 signaling pathways
Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology
Year: 2019

MicroRNA-101 inhibits lung cancer growth and invasion through regulation of EZH2
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010

Adenovirus-mediated E2F-1 gene transfer in nonsmall-cell lung cancer induces cell growth arrest and apoptosis
Source: Eur Respir J 2002; 20: 703-709
Year: 2002



NTHi-promoted proliferation of K-ras-induced early lung cancer lesions is fully dependent on Toll-like receptor signaling
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017

Differences in growth signaling pathway activation in small cell and non-small cell carcinomas of the lung
Source: Eur Respir J 2006; 28: Suppl. 50, 326s
Year: 2006

KPNB1-mediated PD-L1 nuclear translocation promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signalling pathway
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020

EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020

Caspase recruitment domain containing protein 9 suppresses non-small cell lung cancer proliferation and invasion via inhibiting MAPK/p38 pathway
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020

GSK-3 inhibition suppresses lung cancer cell survival, metastasis and proliferation through down-regulation the phosphorylation sites of CAP1
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017

LSC - 2021 - cAMP response element-binding protein mediates immune-evasion of KRAS-mutant lung adenocarcinoma
Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer
Year: 2021



Adenylate cyclase-associated protein 1 is associated with metastasis of non-small cell lung cancer especially in brain metastasis patients and promotes the lung cancer cell proliferation and migration in vitro as well as its growth and metastasis in vivo by the signaling pathways of limk1-cofilin
Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours
Year: 2015


Immunohistochemical studies of COX-2, MMP-9, p53 and VEGF in non-small-cell lung cancer, specifically squamous cell carcinoma and adenocarcinoma
Source: Eur Respir J 2006; 28: Suppl. 50, 387s
Year: 2006

RON tyrosine kinase mutations in brain metastases from lung cancer
Source: ERJ Open Res, 4 (1) 00083-2017; 10.1183/23120541.00083-2017
Year: 2018



Telomerase activation in a model of lung adenocarcinoma
Source: Eur Respir J 2006; 27: 1175-1182
Year: 2006



Overexpression of LincR-PICALM promotes lung cancer proliferation and metastasis by miR-199a-3p suppression and cis- regulation
Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD
Year: 2019

Toll-like receptor 3 is up-regulated and enhances anti-proliferative function in human non-small cell lung cancer
Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs
Year: 2008